Gemina Laboratories (XCNQ:GLAB) Short-Term Debt : C$1.00 Mil (As of Apr. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Short-Term Debt?

Gemina Laboratories's Short-Term Debt for the quarter that ended in Apr. 2024 was C$1.00 Mil.

Gemina Laboratories's quarterly Short-Term Debt stayed the same from Oct. 2023 (C$0.20 Mil) to Jan. 2024 (C$0.20 Mil) but then increased from Jan. 2024 (C$0.20 Mil) to Apr. 2024 (C$1.00 Mil).

Gemina Laboratories's annual Short-Term Debt stayed the same from Jan. 2022 (C$0.00 Mil) to Jan. 2023 (C$0.00 Mil) but then increased from Jan. 2023 (C$0.00 Mil) to Jan. 2024 (C$0.20 Mil).

Gemina Laboratories Short-Term Debt Historical Data

The historical data trend for Gemina Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Short-Term Debt Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Short-Term Debt

0.20

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Short-Term Debt	Get a 7-Day Free Trial								-	-	0.20	0.20	1.00

Gemina Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Gemina Laboratories Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

GLABF:USA

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories Headlines

No Headlines